373 related articles for article (PubMed ID: 8594683)
1. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
[TBL] [Abstract][Full Text] [Related]
2. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
[TBL] [Abstract][Full Text] [Related]
3. Leishmaniasis in Sudan. Mucosal leishmaniasis.
el-Hassan AM; Zijlstra EE
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S19-26. PubMed ID: 11370249
[TBL] [Abstract][Full Text] [Related]
4. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
[TBL] [Abstract][Full Text] [Related]
5. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
[TBL] [Abstract][Full Text] [Related]
6. Post kala-azar ocular leishmaniasis.
el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
[TBL] [Abstract][Full Text] [Related]
7. Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis.
Mahdi M; Elamin EM; Melville SE; Musa AM; Blackwell JM; Mukhtar MM; Elhassan AM; Ibrahim ME
Infect Genet Evol; 2005 Jan; 5(1):29-33. PubMed ID: 15567136
[TBL] [Abstract][Full Text] [Related]
8. Leishmaniasis in Sudan. Visceral leishmaniasis.
Zijlstra EE; el-Hassan AM
Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
[TBL] [Abstract][Full Text] [Related]
9. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
[TBL] [Abstract][Full Text] [Related]
10. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.
Singh A; Ramesh V; Ramam M
Indian J Dermatol Venereol Leprol; 2015; 81(1):29-34. PubMed ID: 25566893
[TBL] [Abstract][Full Text] [Related]
11. Leishmaniasis of the nose caused by different species of Leishmania in the Sudan. Distinguishing features of the different clinical forms.
el-Hassan AM; Yagi HI; Zijlstra EE; el-Kadarow AI
Trop Geogr Med; 1994; 46(1):33-6. PubMed ID: 8165735
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
Singh S ; Kumar J; Singh R; Dwivedi SN
Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
[TBL] [Abstract][Full Text] [Related]
13. Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency.
Rathnayake D; Ranawake RR; Sirimanna G; Siriwardhane Y; Karunaweera N; De Silva R
Int J Dermatol; 2010 May; 49(5):549-51. PubMed ID: 20534090
[TBL] [Abstract][Full Text] [Related]
14. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
Toran KC; Sah SP; Joshi A; Rani S
Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
[TBL] [Abstract][Full Text] [Related]
15. Oral leishmaniasis associated with kala-azar. A case report.
Abbas K; el Toum IA; el Hassan AM
Oral Surg Oral Med Oral Pathol; 1992 May; 73(5):583-4. PubMed ID: 1325634
[TBL] [Abstract][Full Text] [Related]
16. Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India.
Tharakan SJ; Peter Cv D; Karthik R; Rupa V; Rose W; Thomas M; Manuel M; Rupali P; Pulimood S; Rao Ajjampur SS
Am J Trop Med Hyg; 2020 Dec; 104(3):928-933. PubMed ID: 33377447
[TBL] [Abstract][Full Text] [Related]
17. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.
Zijlstra EE
PLoS Negl Trop Dis; 2014; 8(11):e3258. PubMed ID: 25412435
[TBL] [Abstract][Full Text] [Related]
18. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
[TBL] [Abstract][Full Text] [Related]
19. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
[TBL] [Abstract][Full Text] [Related]
20. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan.
Zijlstra EE; Ali MS; el-Hassan AM; el-Toum IA; Satti M; Ghalib HW; Kager PA
Trans R Soc Trop Med Hyg; 1991; 85(4):474-6. PubMed ID: 1755052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
